1. Home
  2. LEVI vs BIO Comparison

LEVI vs BIO Comparison

Compare LEVI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Levi Strauss & Co

LEVI

Levi Strauss & Co

HOLD

Current Price

$21.41

Market Cap

9.1B

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$320.38

Market Cap

8.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEVI
BIO
Founded
1853
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
8.7B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
LEVI
BIO
Price
$21.41
$320.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
4
Target Price
$26.31
$358.50
AVG Volume (30 Days)
1.7M
179.0K
Earning Date
01-28-2026
02-12-2026
Dividend Yield
2.62%
N/A
EPS Growth
303.84
N/A
EPS
1.51
N/A
Revenue
$6,589,400,000.00
$2,557,500,000.00
Revenue This Year
N/A
$1.62
Revenue Next Year
$5.34
$2.26
P/E Ratio
$14.15
N/A
Revenue Growth
11.22
N/A
52 Week Low
$12.17
$211.43
52 Week High
$24.82
$373.69

Technical Indicators

Market Signals
Indicator
LEVI
BIO
Relative Strength Index (RSI) 49.99 57.87
Support Level $21.21 $313.88
Resistance Level $22.13 $326.43
Average True Range (ATR) 0.50 7.67
MACD 0.03 2.07
Stochastic Oscillator 54.75 74.22

Price Performance

Historical Comparison
LEVI
BIO

About LEVI Levi Strauss & Co

Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: